PAK4 expression was increased by SEs in ESCC cells, and pharmaceutical inhibition of this kinase with KPT-9274 remarkably blocked the growth of ESCC cells [14]. This evidence concerns the gene PAK4 and esophageal squamous cell carcinoma.